🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Central nervous system (CNS) relapses of aggressive lymphomas are a rare bu...
Status
Unknown
Location
Charité Universitätsmedizin
Start Date
2007-10
Trial ID
NCT01148173
Treatments Being Tested
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This is a Phase II multi-center trial single arm trial of autologous transp...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2021-10-25
Trial ID
NCT04975698
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2014-06-17
Trial ID
NCT01926665
Treatments Being Tested
Clinical trial investigating the chemotherapeutic compound treosulfan (Trec...
Status
Recruiting
Location
Departement of Medical Oncology, University Hospital Berne
Start Date
2023-06-06
Trial ID
NCT05636787
Treatments Being Tested
This study is testing a combination of chemo-immuno therapy called RBM. RBM...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-11-20
Trial ID
NCT03352765
Treatments Being Tested
This study consists of two sequential treatment phases. In the first phase,...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2025-05-09
Trial ID
NCT06996132
Treatments Being Tested
This is a multicentre; single arm study in subjects with newly diagnosed mu...
Status
Completed
Location
Shanghai Changzheng Hospital
Start Date
2012-12
Trial ID
NCT01852799
Treatments Being Tested
The purpose of this study is to determine if bortezomib when added to conso...
Status
Completed
Location
Multiple Locations
Start Date
2012-01-13
Trial ID
NCT01539083
Treatments Being Tested
This study evaluates the efficacy and safety of the combination of idarubic...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2024-01-01
Trial ID
NCT06232694